Ma Peng-Tao, Wu Ning-Ning, Pei Rong
Department of Stomatology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital. Zhengzhou 450053, China. E-mail:
Shanghai Kou Qiang Yi Xue. 2018 Oct;27(5):526-529.
To study the effect of Kangfuxin liquid combined with Garlicin Capsules in treatment of children with recurrent oral ulcer (ROU) and on immunological regulation.
This randomized controlled clinical study prospectively enrolled 204 patients with ROU who were randomly divided into 2 groups. Patients in group A received Garlicin Capsules 1/time, 3 times/d, combined with Kangfuxin liquid 10 mL to gargle 3 times/d; patients in group B only received Kangfuxin liquid 10 mL gargle 5 min, 3/d. The treatment lasted for 2 weeks. The curative effect was compared before and after treatment, including ulcer surface pain (VAS score), time of ulcer healing, and the changes of T cell subsets (CD3, CD4, CD8 and CD4/CD8) before and after treatment were compared by SPSS 22 software package.
Ulcer healing time (3.5±0.6) d, duration of pain (3.1±0.3)d in group A were shorter than in group B (P<0.05); treatment efficiency was 96.08% in group A, 88.24% in group B( χ=6.264, P<0.05). The pain scores of both groups were significantly reduced after treatment, and the difference was significant between group A and group B [(1.1±0.4) vs (3.2± 0.6)] (P<0.05). The levels of CD3, CD4, CD4/CD8 in group A were significantly higher than those in group A after treatment (P<0.05), the levels of CD8+ was significant lower than in group B (P<0.05).
Kangfuxin liquid combined with Garlicin Capsules can improve the therapeutic effect of ROU and repair of local damaged mucosa in children, increasing the immune function of children.
探讨康复新液联合大蒜素胶囊治疗小儿复发性口腔溃疡(ROU)的疗效及对免疫调节的影响。
本随机对照临床研究前瞻性纳入204例ROU患儿,随机分为2组。A组患儿口服大蒜素胶囊,1次/次,3次/d,同时用康复新液10 mL含漱,3次/d;B组患儿仅用康复新液10 mL含漱5分钟,3次/d。疗程为2周。比较治疗前后的疗效,包括溃疡面疼痛(VAS评分)、溃疡愈合时间,并采用SPSS 22软件包比较治疗前后T细胞亚群(CD3、CD4、CD8及CD4/CD8)的变化。
A组溃疡愈合时间为(3.5±0.6)d,疼痛持续时间为(3.1±0.3)d,均短于B组(P<0.05);A组治疗有效率为96.08%,B组为88.24%(χ=6.264,P<0.05)。两组治疗后疼痛评分均显著降低,且A组与B组比较差异有统计学意义[(1.1±0.4)分 vs (3.2±0.6)分](P<0.05)。A组治疗后CD3、CD4、CD4/CD8水平均显著高于治疗前(P<0.05),CD8+水平显著低于B组(P<0.05)。
康复新液联合大蒜素胶囊可提高小儿ROU的治疗效果,促进局部受损黏膜修复,增强小儿免疫功能。